3 days ago · LIMITATIONS: The study relied on self-reported health conditions, which may have introduced reporting or recall biases. The measure of multimorbidity included only nine physical …

Jan 30, 2026 · The positive opinion follows a re-examination after authorization was initially refused last October.

Jan 29, 2026 · DPP-1 inhibitors and macrolides likely reduce the frequency of exacerbations in patients with non-cystic fibrosis bronchiectasis compared with placebo, a network meta-analysis shows.

Jan 11, 2026 · Cutaneous adverse events associated with GLP-1 receptor agonists are uncommon but vary by agent, a study of FDA data shows.

5 days ago · The EMA’s positive opinion on Kygevvi marks a turning point for patients with TK2d, an ultra-rare genetic muscle disease previously managed only with supportive care.

May 17, 2024 · TOPLINE: About 4 per 1000 individuals develop a new-onset systemic autoimmune disease after the COVID-19 vaccination, with myopathies, arthritis, and polymyalgia rheumatica …

Mar 31, 2025 · Atopic dermatitis highlights from AAD 2025 include phase 3 trial results on rocatinlimab and delgocitinib, findings on tapinarof 1% cream, and early dosing data on a new JAK1/TYK2 inhibitor.

4 days ago · Consuming lavender tea for 14 days is linked to a reduction in symptoms of misophonia in adult patients, as well as reduced depression, anxiety, and anger, a new study shows.

Jan 16, 2026 · The trial is the first phase 3 study to demonstrate a significant reduction in monthly migraine and headache days with fremanezumab for episodic migraine in this patient population.

It tends to be aggressive, nodular, and cavitary. If a patient is colonized with MRSA and develops a cavitary, nodular pneumonia, that makes me strongly suspect MRSA as the cause.